SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hamayon Babary, Xibei Liu, Yosef Ayatollahi, Xin P. Chen, Loomee Doo, Lakshmi K. Uppaluru, Myoung K. Kwak, Catherine Kulaga, Dodji Modjinou, Ewa Olech, Ji W. Yoo, Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta-analysis, International Journal of Rheumatic Diseases, 2018, 21, 1
  2. 2
    Mayra Giannelou, Clio P. Mavragani, Cardiovascular disease in systemic lupus erythematosus: A comprehensive update, Journal of Autoimmunity, 2017, 82, 1

    CrossRef

  3. 3
    Melinda Zsuzsanna Szabó, Peter Szodoray, Emese Kiss, Dyslipidemia in systemic lupus erythematosus, Immunologic Research, 2017, 65, 2, 543

    CrossRef

  4. 4
    Luis Alonso González, Graciela S. Alarcón, The evolving concept of SLE comorbidities, Expert Review of Clinical Immunology, 2017, 13, 8, 753

    CrossRef

  5. 5
    C. Nardin, M. Rattazzi, P. Pauletto, The Heart in Systemic Autoimmune Diseases, 2017,

    CrossRef

  6. 6
    K. Tselios, M.B. Urowitz, The Heart in Rheumatic, Autoimmune and Inflammatory Diseases, 2017,

    CrossRef

  7. 7
    Joan T. Merrill, Antiphospholipid Syndrome in Systemic Autoimmune Diseases, 2017,

    CrossRef

  8. 8
    John G. Hanly, Li Su, Murray B. Urowitz, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Sasha Bernatsky, Ann E. Clarke, Daniel J. Wallace, Joan T. Merrill, David A. Isenberg, Anisur Rahman, Ellen M. Ginzler, Michelle Petri, Ian N. Bruce, M. A. Dooley, Paul Fortin, Dafna D. Gladman, Jorge Sanchez-Guerrero, Kristjan Steinsson, Rosalind Ramsey-Goldman, Munther A. Khamashta, Cynthia Aranow, Graciela S. Alarcón, Barri J. Fessler, Susan Manzi, Ola Nived, Gunnar K. Sturfelt, Asad A. Zoma, Ronald F. van Vollenhoven, Manuel Ramos-Casals, Guillermo Ruiz-Irastorza, S. Sam Lim, Kenneth C. Kalunian, Murat Inanc, Diane L. Kamen, Christine A. Peschken, Soren Jacobsen, Anca Askanase, Chris Theriault, Vernon Farewell, A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach, Arthritis & Rheumatology, 2016, 68, 8
  9. 9
    Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, Jacqueline M McBride, Michael J Townsend, Xiaohui Wei, John C Davis, William P Kennedy, A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE), Annals of the Rheumatic Diseases, 2016, 75, 1, 196

    CrossRef

  10. 10
    Konstantinos Tselios, Charalambos Koumaras, Dafna D. Gladman, Murray B. Urowitz, Dyslipidemia in systemic lupus erythematosus: just another comorbidity?, Seminars in Arthritis and Rheumatism, 2016, 45, 5, 604

    CrossRef

  11. 11
    A.A. Ngaïdé, F. Ly, K. Ly, M Diao, Ad. Kane, A. Mbaye, M. Lèye, F. Aw, S.A. Sarr, M. Dioum, C.T Ndao, N.D. Gaye, M.B. Ndiaye, M. Bodian, M.B. Bah, M. Ndiaye, A.F. Cissé, I. Kouamé, A. Tabane, J.S. Mingou, P. Thiombiano, A. Kane, S.A. Bâ, Les manifestations cardio-vasculaires au cours du lupus érythémateux systémique à Dakar : étude descriptive à propos de 50 cas, Bulletin de la Société de pathologie exotique, 2016, 109, 5, 345

    CrossRef

  12. 12
    Laura B. Lewandowski, Mariana J. Kaplan, Update on cardiovascular disease in lupus, Current Opinion in Rheumatology, 2016, 28, 5, 468

    CrossRef

  13. 13
    Rekha Mankad, Atherosclerotic Vascular Disease in the Autoimmune Rheumatologic Patient, Current Atherosclerosis Reports, 2015, 17, 4

    CrossRef

  14. 14
    Gordana Bogdanovic, Ljudmila Stojanovich, Aleksandra Djokovic, Natasa Stanisavljevic, Physical Activity Program Is Helpful for Improving Quality of Life in Patients with Systemic Lupus Erythematosus, The Tohoku Journal of Experimental Medicine, 2015, 237, 3, 193

    CrossRef

  15. 15
    Apinya Lertratanakul, Peggy Wu, Alan Dyer, Murray Urowitz, Dafna Gladman, Paul Fortin, Sang-Cheol Bae, Caroline Gordon, Ann Clarke, Sasha Bernatsky, John G. Hanly, David Isenberg, Anisur Rahman, Joan Merrill, Daniel J. Wallace, Ellen Ginzler, Munther Khamashta, Ian Bruce, Ola Nived, Gunnar Sturfelt, Kristjan Steinsson, Susan Manzi, Mary Anne Dooley, Kenneth Kalunian, Michelle Petri, Cynthia Aranow, Josep Font, Ronald Vollenhoven, Thomas Stoll, Rosalind Ramsey-Goldman, 25-Hydroxyvitamin D and Cardiovascular Disease in Patients With Systemic Lupus Erythematosus: Data From a Large International Inception Cohort, Arthritis Care & Research, 2014, 66, 8
  16. 16
    L. Arnaud, A. Mathian, E. Bruckert, Z. Amoura, Le risque cardiovasculaire au cours du lupus systémique, La Revue de Médecine Interne, 2014, 35, 11, 723

    CrossRef

  17. 17
    Patricia K. Weinstein, Ali Amirkhosravi, Theodore J. Angelopoulos, Angeline Bushy, Maureen M. Covelli, Karen E. Dennis, Reducing Cardiovascular Risk in Women With Lupus, The Journal of Cardiovascular Nursing, 2014, 29, 2, 130

    CrossRef

  18. 18
    Jaime Calvo-Alén, Lucía Silva-Fernández, Eduardo Úcar-Angulo, José María Pego-Reigosa, Alejandro Olivé, Carmen Martínez-Fernández, Víctor Martínez-Taboada, José Luis Marenco, Estíbaliz Loza, Javier López-Longo, Juan Jesús Gómez-Reino, María Galindo-Izquierdo, Antonio Fernández-Nebro, María José Cuadrado, María Ángeles Aguirre-Zamorano, Antonio Zea-Mendoza, Íñigo Rúa-Figueroa, Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico, Reumatología Clínica, 2013, 9, 5, 281

    CrossRef

  19. 19
    DJ Wallace, S Navarra, MA Petri, A Gallacher, M Thomas, R Furie, RA Levy, RF van Vollenhoven, S Cooper, ZJ Zhong, W Freimuth, R Cervera, Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus, Lupus, 2013, 22, 2, 144

    CrossRef

  20. 20
    Jaime Calvo-Alén, Lucía Silva-Fernández, Eduardo Úcar-Angulo, José María Pego-Reigosa, Alejandro Olivé, Carmen Martínez-Fernández, Víctor Martínez-Taboada, José Luis Marenco, Estíbaliz Loza, Javier López-Longo, Juan Jesús Gómez-Reino, María Galindo-Izquierdo, Antonio Fernández-Nebro, María José Cuadrado, María Ángeles Aguirre-Zamorano, Antonio Zea-Mendoza, Íñigo Rúa-Figueroa, SER Consensus Statement on the Use of Biologic Therapy for Systemic Lupus Erythematosus, Reumatología Clínica (English Edition), 2013, 9, 5, 281

    CrossRef

  21. 21
    CA Mancuso, M Perna, AB Sargent, JE Salmon, A pilot study of office-based spirometry in patients with systemic lupus erythematosus, Lupus, 2012, 21, 12, 1343

    CrossRef

  22. 22
    J. Canora-Lebrato, R. Barba-Martín, I. Perales-Fraile, J. Marco-Martínez, S. Plaza-Cantelli, A. Zapatero-Gaviria, Descripción de las altas hospitalarias en pacientes con lupus eritematoso sistémico, Revista Clínica Española, 2012, 212, 9, 432

    CrossRef

  23. You have free access to this content23
    Joan T. Merrill, Ellen M. Ginzler, Daniel J. Wallace, James D. McKay, Jeffrey R. Lisse, Cynthia Aranow, Frank R. Wellborne, Michael Burnette, John Condemi, Z. John Zhong, Lilia Pineda, Jerry Klein, William W. Freimuth, Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus, Arthritis & Rheumatism, 2012, 64, 10
  24. 24
    K Eriksson, E Svenungsson, H Karreskog, I Gunnarsson, J Gustafsson, S Möller, S Pettersson, C Boström, Physical activity in patients with systemic lupus erythematosus and matched controls, Scandinavian Journal of Rheumatology, 2012, 41, 4, 290

    CrossRef

  25. 25
    Deborah P. M. Symmons, Sherine E. Gabriel, Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE, Nature Reviews Rheumatology, 2011, 7, 7, 399

    CrossRef

  26. 26
    Mariko L. Ishimori, Rebecca Martin, Daniel S. Berman, Pavel Goykhman, Leslee J. Shaw, Chrisandra Shufelt, Piotr J. Slomka, Louise E.J. Thomson, Jay Schapira, Yuching Yang, Daniel J. Wallace, Michael H. Weisman, C. Noel Bairey Merz, Myocardial Ischemia in the Absence of Obstructive Coronary Artery Disease in Systemic Lupus Erythematosus, JACC: Cardiovascular Imaging, 2011, 4, 1, 27

    CrossRef

  27. 27
    CA Mancuso, M Perna, AB Sargent, JE Salmon, Perceptions and measurements of physical activity in patients with systemic lupus erythematosus, Lupus, 2011, 20, 3, 231

    CrossRef

  28. 28
    Maureen McMahon, Bevra H Hahn, Brian J Skaggs, Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention, Expert Review of Clinical Immunology, 2011, 7, 2, 227

    CrossRef

  29. 29
    DA Isenberg, R Ramsey-Goldman, D Gladman, JG Hanly, The Systemic Lupus International Collaborating Clinics (SLICC) group – It was 20 years ago today, Lupus, 2011, 20, 13, 1426

    CrossRef

  30. 30
    Caroline Gordon, Rheumatology, 2011,

    CrossRef

  31. 31
    M. B. Urowitz, D. Gladman, D. Ibañez, S. C. Bae, J. Sanchez-Guerrero, C. Gordon, A. Clarke, S. Bernatsky, P. R. Fortin, J. G. Hanly, D. J. Wallace, D. Isenberg, A. Rahman, G. S. Alarcón, J. T. Merrill, E. Ginzler, M. Khamashta, O. Nived, G. Sturfelt, I. N. Bruce, K. Steinsson, S. Manzi, R. Ramsey-Goldman, M. A. Dooley, A. Zoma, K. Kalunian, M. Ramos, R. F. Van Vollenhoven, C. Aranow, T. Stoll, M. Petri, P. Maddison, Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus, Arthritis Care & Research, 2010, 62, 6
  32. 32
    Chak Sing Lau, R. Handa, Cardiovascular co-morbidity in Asians with lupus: theoretical concern or clinical reality?, Lupus, 2010, 19, 12, 1447

    CrossRef

  33. 33
    Z. Barta, MJ Harrison, T. Wangrangsimakul, J. Shelmerdine, L-S. Teh, M. Pattrick, H. Edlin, N. Dale, Y. Ahmad, IN Bruce, Health-related quality of life, smoking and carotid atherosclerosis in white British women with systemic lupus erythematosus, Lupus, 2010, 19, 3, 231

    CrossRef

  34. 34
    Liang-Jing Lu, Daniel J. Wallace, Sandra V. Navarra, Michael H. Weisman, Lupus Registries: Evolution and Challenges, Seminars in Arthritis and Rheumatism, 2010, 39, 4, 224

    CrossRef

  35. 35
    Carly Skamra, Rosalind Ramsey-Goldman, Management of cardiovascular complications in systemic lupus erythematosus, International Journal of Clinical Rheumatology, 2010, 5, 1, 75

    CrossRef

  36. 36
    Allison B. Reiss, Effects of inflammation on cholesterol metabolism: Impact on systemic lupus erythematosus, Current Rheumatology Reports, 2009, 11, 4, 255

    CrossRef

  37. 37
    RA Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, T Vollmer, High frequency of adverse health behaviors in multiple sclerosis, Multiple Sclerosis Journal, 2009, 15, 1, 105

    CrossRef

  38. 38
    Michael S Boger, Ayumi Shintani, Leigh Anne Redhage, Valerie Mitchell, David W Haas, Jason D Morrow, Todd Hulgan, Highly Sensitive C-Reactive Protein, Body Mass Index, and Serum Lipids in HIV-Infected Persons Receiving Antiretroviral Therapy: A Longitudinal Study, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2009, 52, 4, 480

    CrossRef

  39. 39
    Colin Edgerton, José C. Crispín, Chantal M. Moratz, Estelle Bettelli, Mohamed Oukka, Milomir Simovic, Athina Zacharia, Ryan Egan, Jie Chen, Jurandir J. Dalle Lucca, Yuang-Taung Juang, George C. Tsokos, IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice, Clinical Immunology, 2009, 130, 3, 313

    CrossRef

  40. 40
    Joan T. Merrill, Antiphospholipid Syndrome in Systemic Autoimmune Diseases, 2009,

    CrossRef

  41. 41
    Berthold Hoppe, Thomas Dörner, Is there a 'window of opportunity' for intervention to reduce risk of coronary artery disease in SLE?, Nature Clinical Practice Rheumatology, 2008, 4, 9, 452

    CrossRef

  42. 42
    José M.ª Pego Reigosa, Sólo lupus: ¡hazlo!, Seminarios de la Fundación Española de Reumatología, 2008, 9, 4, 191

    CrossRef

  43. 43
    Murray B. Urowitz, Dafna D. Gladman, The SLICC inception cohort for atherosclerosis, Current Rheumatology Reports, 2008, 10, 4, 281

    CrossRef